Bio Solution

Seoul, South Korea Founded: 2000 • Age: 26 yrs
Cell therapies are developed using somatic and stem cell platforms.
Request Access

About Bio Solution

Bio Solution is a company based in Seoul (South Korea) founded in 2000.. The company has 88 employees as of December 31, 2024. Bio Solution operates in a competitive market with competitors including Incyte, LEO Pharma, Formation Bio, Arcutis and Tenaya Therapeutics, among others.

  • Headquarter Seoul, South Korea
  • Employees 88 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Bio Solution Co., Ltd.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $8.74 M (USD)
    3.42
    as on Dec 31, 2024
  • Net Profit
    $-8.09 M (USD)
    -779.36
    as on Dec 31, 2024
  • EBITDA
    $-2.45 M (USD)
    -20.8
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    88

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Bio Solution

Bio Solution is a publicly listed company on the KRX with ticker symbol 086820 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: KRX · Ticker: 086820 . Sector: Health technology · South Korea

Funding Insights of Bio Solution

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Bio Solution

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Bio Solution

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bio Solution Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Bio Solution

Bio Solution operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, LEO Pharma, Formation Bio, Arcutis and Tenaya Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Developer of drugs for treating dermatology diseases
domain founded_year HQ Location
AI-powered drug discovery platform for various diseases
domain founded_year HQ Location
Immunotherapeutic solutions for dermatological conditions are developed.
domain founded_year HQ Location
Regenerative and gene therapeutics for heart failure are developed.
domain founded_year HQ Location
Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bio Solution

Frequently Asked Questions about Bio Solution

When was Bio Solution founded?

Bio Solution was founded in 2000.

Where is Bio Solution located?

Bio Solution is headquartered in Seoul, South Korea.

How many employees does Bio Solution have?

As of Dec 31, 2024, the latest employee count at Bio Solution is 88.

What is the annual revenue of Bio Solution?

Annual revenue of Bio Solution is $8.74M as on Dec 31, 2024.

What does Bio Solution do?

Biosolution is developing cell therapies using its somatic and stem cell technology platforms. The product portfolio includes KeraHeal ( a sprayable autologous keratinocyte for severe burns), KeraHeal-Allo (hydrogel based allogeneic keratinocyte therapy). Both these products are approved. Another cell therapy, CartiLife (spherical autologous chondrocytes for arthritis) in in the phase 2 trials. The company is also offering services such as human tissue models, raw materials for cosmetic treatments (skin-regenerating peptide , primary cells in vitro testing services for safety efficacy of drugs, cosmetics and their raw materials.

Who are the top competitors of Bio Solution?

Bio Solution's top competitors include LEO Pharma, Formation Bio and Arcutis.

Is Bio Solution publicly traded?

Yes, Bio Solution is publicly traded on KRX under the ticker symbol 086820.

What is Bio Solution's ticker symbol?

The ticker symbol of Bio Solution is 086820 on KRX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available